Measuring central action of acute antimigraine drugs in humans

Timsit-Berthier M , Mautanus H , Poucclet H , Maussiaux P , Legros JJ. Contingent negative variation as a new method to assess the catecholaminergic systems. In: Gallai V , editor. Maturation of the CNS and evoked potentials. Amsterdam: Elsevier, 1986: 260–7

Schoenen J , Maertens de Noordhout A , Timsit-Berthier M , Timsit M. Contingent negative variation (CNV) as a diagnostic and physiopathologic tool in headache patients. In: Clifford Rose F , editor. Migraine: Clinical and Research Advances. Karger: Basel, 1985: 17–25

Kropp P , Gerber WD. Is increased amplitude of contingent negative variation in migraine due to cortical hyperactivity or to reduced habituation? Cephalalgia 1993; 13: 37–41

Maertens de Noordhout A , Timsit-Berthier M , Timsit M , Schoenen J. Effects of beta-blockade on contingent negative variation in migraine. Ann Neurol 1987; 21: 111–12

Schoenen J. Clinical neurophysiology studies in headache: a review of data and pathophysiological hints. Funct Neurol 1992; 7: 191–204

Schoenen J , Wang W , Albert A , Delwaide PJ. Potentiation instead of habituation characterises visual evoked potentials in migraine patients between attacks. Eur J Neurol 1995; 2: 115–22

Áfra J , Proietti-Cecchini A , De Pasque U , Schoenen J. Visual evoked potentials during long duration stimulation in migraine patients between attacks (Abstract). Headache 1996; 36: 261

Mesulam MM. Large-scale neurocognitive networks and distributed processing for attention, language and memory. Ann Neurol 1990; 28: 597–613

Hegerl U , Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 1993; 33: 173–87

Wang W , Timsit-Berthier M , Schoenen J. Intensity dependence of auditory evoked potentials in migraine: an indication of cortical potentiation and low serotonergic neurotransmission. Neurology 1996; 46: 1404–9

Pascual J , del Arco C , Romon T , del Olmo E , Castro E , Pazos A. Autoradiographic distribution of [3H]sumatriptan-binding sites in post-mortem human brain. Cephalalgia 1996; 16: 317–22

Ferrari MD. Biochemistry of migraine. Pathol Biol 1992; 40: 284–92

Proietti-Cecchini AP , Áfra J , Schoenen J. 311C90, a 5-HT1B/1D agonist, is able to modify central serotonergic neurotransmission in man: evidence from a study of the intensity dependence of the cortical auditory evoked potential 1997; in press

Mitsikostas DD , Papadopoulou-Daifotis , Sifkakis A , Varanos D. The effect of sumatriptan on brain monoamines in rats. Headache 1996; 36: 29–31

Hay KM , Mortimer MJ , Barker DC , Debney LM , Good PA. 1044 women with migraine: the effect of environmental stimuli. Headache 1994; 34: 166–8

Marcus DA , Soso MJ. Migraine and stripe induced visual discomfort. Arch Neurol 1989; 46: 1129–32

Maertens de Noordhout A , Timsit-Berthier M , Timsit M , Schoenen J. Effects of beta-blockade on contingent negative variation in migraine. Ann Neurol 1987; 21: 111–12

Hegerl U , Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 1993; 33: 173–87

Knott JR , Irwin DA. Anxiety, stress and contingent negative variation. Arch Gen Psychiatry 1973; 29: 538–41